3,134 publications from this institution
The authors wish to make the following correction to paper [1], doi:10.3390/molecules190812173, website: http://www.mdpi.com/1420-3049/19/8/12173.[...]
Several prospective trials consistently document asleep SBP mean and sleep-time relative SBP decline (dipping) constitute highly significant CVD risk factors, independent of OBPM. Bedtime, compared to customary upon-waking, hypertension chronotherapy reduces risk of major CVD events. Collectively, these findings call for new definition of true hypertension and, accordingly, its proper diagnosis and management.
We have examined prospectively whether the tolerance-hyperbaric test (THT), combined approach of establishing tolerance intervals for the circadian variability of blood pressure (BP) as a function of gestational age, and then computing the hyperbaric index (HBI, area of BP excess above the upper limit of the interval) by comparison of any patient's BP profile with those intervals, provides high sensitivity for the early identification of pregnant women who subsequently will develop hypertensive complications in pregnancy. We analyzed 2,014 BP series obtained from 176 women with uncomplicated pregnancies and 121 women who developed gestational hypertension or preeclampsia (gestational hypertension and proteinuria, above 300 mg/24 hours in urine). BP was sampled at half-hour intervals during the day and hourly during the night for 48 hours with an ABPM-630 Colin device once every 4 weeks from the first visit to the hospital (mostly before 14 weeks of gestation) until delivery. Circadian 90% tolerance limits for BP were computed as a function of trimester of gestation from 497 series previously sampled from a reference group of 189 normotensive pregnant women [Hermida RC, et al. J Perinat Med 1997;25:237–253]. Sensitivity of the THT was 91% for women sampled during the first trimester of gestation, and increased up to 99% in the third trimester. Specificity for a threshold HBI value for diagnosis of 15 mmHgXhour obtained from previous studies [Hermida RC, et al. Hypertension 1998;31:83–88] was above 99% in all trimesters. The positive and negative predictive values were above 95% in all trimesters. The test provided, on the average, an early identification of gestational hypertension and preeclampsia 23 weeks prior to the clinical confirmation of the disease. The THT, now validated prospectively in women systematically sampled by ambulatory monitoring throughout pregnancy, represents a reproducible, noninvasive, and high sensitivity test for the very early identification of subsequent gestational hypertension and preeclampsia.
Angiotensin II receptor blockers (ARBs) are a relatively new class of antihypertensive medications that selectively and specifically antagonize the action of angiotensin II, a potent vasoconstrictor impacting blood pressure (BP) regulation. Valsartan is an orally active, specific, and selective ARB. After a single oral dose, the onset of its BP lowering action is within 2 hours, with peak effect occurring within 4–6 hours. We investigated the effects of valsartan on the 24-hour BP profile of hypertensive patients. We studied 187 patients with grade 1–2 essential hypertension (63 men), 50.4±13.3 (mean±SD) years of age, assigned to receive valsartan monotherapy (160 mg/day). BP was measured by ambulatory monitoring at 20-min intervals from 07:00 to 23:00 hours and at 30-min intervals at night for 48 consecutive hours before and after 3 months of treatment. Physical activity was simultaneously monitored every minute by wrist actigraphy, and the information used to determine diurnal and nocturnal means of BP for each patient according to individual resting time. Valsartan treatment resulted in a highly statistically significant reduction in BP from baseline after 3 months of treatment (14.8 and 10.5 mm Hg reduction in the 24-hour mean of systolic and diastolic BP, respectively; P<0.001). The BP reduction was highly significant (after correcting for multiple testing) at each of the 24 hourly means (P always <0.001). There was no effect of valsartan on heart rate (increase in the 24-hour mean of 0.17 beats/min, P=0.862). The circadian pattern of physical activity also remained unchanged (24-hour mean of 128 and 127 counts/min before and after treatment, respectively; P=0.661). There was also a highly significant reduction (P<0.001) of 4.3 mm Hg in the 24-hour mean of pulse pressure (PP). Results indicate that, despite its relatively short half-life, 160 mg/day valsartan efficiently reduce BP for the whole 24 hours of the day. Moreover, valsartan significantly reduces PP during the 24 hours. Apart from the progressive rise of PP with aging, a significant increase in PP has been documented, among other groups of interest, in hypertensive patients with type 2 diabetes. Thus, valsartan could be chosen, for added cardiovascular risk reduction, in the treatment of the elderly and diabetics with elevated PP, an issue that deserves further prospective investigation. Am J Hypertens (2004) 17, 110A–110A; doi: 10.1016/j.amjhyper.2004.03.284
Hermida, R C; Calvo, C; Ayala, D E; Dominguez, M J; Covelo, M; Mojon, A; Fernandez, J R; Lopez, J E Author Information
Abstract Throughout the living world, genetic recombination and nucleotide substitution are the primary processes that create the genetic variation upon which natural selection acts. Just as analyses of substitution patterns can reveal a great deal about evolution, so too can analyses of recombination. Evidence of genetic recombination within the genomes of apparently asexual species can equate with evidence of cryptic sexuality. In sexually reproducing species, nonrandom patterns of sequence exchange can provide direct evidence of population subdivisions that prevent certain individuals from mating. Although an interesting topic in its own right, an important reason for analysing recombination is to account for its potentially disruptive influences on various phylogenetic‐based molecular evolution analyses. Specifically, the evolutionary histories of recombinant sequences cannot be accurately described by standard bifurcating phylogenetic trees. Taking recombination into account can therefore be pivotal to the success of selection, molecular clock and various other analyses that require adequate modelling of shared ancestry and draw increased power from accurately inferred phylogenetic trees. Here, we review various computational approaches to studying recombination and provide guidelines both on how to gain insights into this important evolutionary process and on how it can be properly accounted for during molecular evolution studies.
Quantitative proteomic changes in the liver of adult males of Sheepshead minnow (Cyprinodon variegatus) upon exposure to ethinyl estradiol (EE2) were assessed to provide an advanced understanding of the metabolic pathways affected by estrogenic endocrine disruption in marine fish, and to identify potential novel molecular biomarkers for the environmental exposure to estrogens. From a total of 3188 identified protein groups (hereafter proteins), 463 showed a statistically significant difference in their abundance between EE2 treatment and solvent control samples. The most affected biological processes upon EE2 exposure were related to ribosomal biogenesis, protein synthesis and transport of nascent proteins to endoplasmic reticulum, and nuclear mRNA catabolism. Within the group of upregulated proteins, a subset of 14 proteins, involved in egg production (Vitellogenin, Zona Pellucida), peptidase activity (Cathepsine E, peptidase S1, Serine/threonine-protein kinase PRP4 homolog, Isoaspartyl peptidase and Whey acidic protein), and nucleic acid binding (Poly [ADP-ribose] polymerase 14) were significantly upregulated with fold-change values higher than 3. In contrast, Collagen alpha-2, involved in the process of response to steroid hormones, among others, was significantly downregulated (fold change = 0.2). This pattern of alterations in the liver proteome of adult males of C. variegatus can be used to identify promising novel biomarkers for the characterization of exposure of marine fish to estrogens. The Whey acidic protein-like showed the highest upregulation in EE2-exposed individuals (21-fold over controls), suggesting the utility of abundance levels of this protein in male liver as a novel biomarker of xenoestrogen exposure.
This study investigated the effects of domestic cooking process on the variations of soybean isoflavones, aiming at understanding the conversion of β-glucosides and aglycones isoflavones during the process and the relation with antioxidant activity. It was found that β-glucosides isoflavones was significantly increased from 223.01 (raw) to 727.29 mg/g (frying at 160 °C for 2 min), but boiling showed only a slight increase to 258.14 mg/g. The process for the mixed cooking of soybeans with vegetables was also evaluated, which is quite common in home cuisine. The results showed all bioactive ingredients were aggressively destroyed by over processing, but interestingly, green pepper and kelp exhibited isoflavones generation potentials for soybean. In addition, cooking from 60 to 160 °C for 2 or 5 min, showed a significantly decrease on FRAP. However, in the case of fried soybeans which treated at 120 °C or 160 °C, when extending the heating time to 5 min, their FRAP activity got a significant increase. The present study may provide a practical guidance for healthy soybean cooking, by using frying around 120 °C for 5 min and mixed with some vegetables such as green peppers or kelp. Keywords: Soybeans, Isoflavones, Cooking processing, Antioxidant activity